Isis/Alnylam Venture Regulus Gets CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Anadys chief executive Xanthopoulos brings experience in building companies from research to development, firms note.
You may also be interested in...
Publication Of Regulus Preclinical Study Derisks Micro RNA Therapeutics
Article in Nature reports anti-miR-21 compound prevents heart failure in mouse model.
Publication Of Regulus Preclinical Study Derisks Micro RNA Therapeutics
Article in Nature reports anti-miR-21 compound prevents heart failure in mouse model.
Regulus Signs Potential $600 Million MicroRNA Collaboration With GSK
Firms will co-develop microRNA targeted therapeutics in inflammation and immunology.